This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Endocyte Inc (ECYT)

NASDAQ: Health Care

Company Balance Sheet
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Assets
Cash and Equivalents 15.43M 45.53M 52.85M 34.00M
Receivables 8.68K 706.40K 6.35M 5.69M
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 493.86K 652.51K 496.34K 3.30M
Total Current Assets 174.88M 127.04M 133.33M 184.82M
Property, Plant & Equipment, Gross 7.76M 7.48M 6.62M 5.30M
Accumulated Depreciation & Depletion 4.36M 3.51M 2.78M 2.13M
Property, Plant & Equipment, Net 3.40M 3.97M 3.84M 3.17M
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 111.61K 81.79M 25.69M 26.09M
Total Non-Current Assets 3.51M 85.76M 29.53M 29.25M
Liabilities & Shareholder Equity
Total Assets 178.39M 212.80M 162.86M 214.08M
Accounts Payable 1.26M 1.23M 5.44M 3.65M
Short Term Debt 0.00 0.00 0.00 12.65K
Other Current Liabilities 0.00 3.14K 18.17K 0.00
Total Current Liabilities 6.19M 6.88M 73.66M 62.47M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 850.45K 912.26K 965.40K 51.99M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 850.45K 912.26K 965.40K 52.04M
Total Liabilities 7.04M 7.80M 74.63M 114.51M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 171.35M 205.00M 88.23M 99.57M
Common Par 42.03K 41.78K 36.16K 35.92K
Additional Paid In Capital 381.12M 373.57M 262.06M 255.36M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -209.73M -168.47M -173.92M -155.89M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments -79.40K -143.93K 56.69K 72.75K
Total Capitalization 171.35M 205.00M 88.23M 99.57M
Total Equity 171.35M 205.00M 88.23M 99.57M
Total Liabilities & Stock Equity 178.39M 212.80M 162.86M 214.08M
Total Common Shares Outstanding 41.78M 41.78M 36.16M 35.92M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 41.94M 40.24M 36.04M 35.86M
Diluted Weighted Shares Outstanding 41.94M 41.76M 36.04M 35.86M
Number of Employees 78 81 91 71
Number of Part-Time Employees 0 0 0 0
ECYT News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Analysts Ratings for ECYT

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET ECYT ANALYST REPORT

ECYT Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs